Mid-term outcomes of the Absorb BVS versus second-generation DES: A systematic review and meta-analysis.

Bioresorbable Vascular Scaffolds (BVS) were introduced to overcome some of the limitations of drug-eluting stent (DES) for PCI. Data regarding the clinical outcomes of the BVS versus DES beyond 2 years are emerging.